For investors looking to balance the search for growth with a level of caution, the "Growth at a Reasonable Price" (GARP) or "Affordable Growth" strategy offers a sensible middle path. This method tries to find companies that are increasing their earnings and revenue at a good rate and are also available at prices that are not too high. By looking for stocks with good growth scores, acceptable financial condition and earnings, and a price that is not extreme, investors can try to assemble a collection of companies ready for future progress without paying a too-high price for that possibility now.
One stock that recently appeared using this type of screening process is MCKESSON CORP (NYSE:MCK), a key part of the worldwide healthcare supply system. The company's basic profile, as shown in a detailed study report, shows a combination of good growth, fair price, and steady basic operations that fit well with the affordable growth idea.
Good Growth Path
The central idea of any growth plan is, expectedly, growth. McKesson performs well here, receiving a Growth Rating of 7 out of 10. The company shows good speed in both its recent results and its planned future direction.
- Past Results: Over the last year, McKesson's Earnings Per Share (EPS) rose by a notable 28.88%, while Revenue increased by 15.49%. This is not a single event; the company has maintained an average yearly EPS increase of 17.17% and revenue increase of 9.22% in recent years.
- Future Predictions: Experts believe this positive pattern will persist, with forecasts indicating average yearly EPS increase of 14.08% and revenue increase of 8.44% in the next years. This steadiness between past results and future predictions gives some assurance in the company's growth plan.
For an affordable growth plan, this steady, double-digit earnings increase is a main draw, indicating the company is effectively growing its business and owner value.
Price Consideration
A stock with high growth can still be a bad investment if its cost is too great. This is where the "reasonable price" part is very important. McKesson's Price Rating of 5 shows a varied but finally acceptable view when seen through the right perspective.
- Industry Comparison: While McKesson's Price-to-Earnings (P/E) ratio of 23.01 might seem high alone, it is actually lower than 64% of similar companies in the Health Care Providers & Services industry. Its Price-to-Forward Earnings ratio shows a similar situation, priced more affordably than 63% of the industry.
- Market and Growth View: Compared to the wider S&P 500, McKesson sells at a small reduction on a trailing P/E basis and a larger reduction on a forward P/E basis. Also, the company's PEG ratio, which includes earnings growth, suggests the current price is suitable given the available growth. The study states that "a higher price may be acceptable" based on predicted earnings growth.
This perspective is important. The screening process looks for stocks that are not overpriced, and McKesson's price, while not very low, seems fair compared to both its own growth speed and its competitive field.
Supporting Basics: Condition and Earnings
Lasting growth seldom exists alone; it needs a firm operational and financial base. McKesson's Condition and Earnings ratings, both at 6, show this needed steadiness.
The company's financial condition is a story of two sides. Its ability to pay debts is very good, with a strong Altman-Z score showing no failure risk and a very good Debt-to-Free-Cash-Flow ratio of 0.68, meaning it could pay all debt in under a year with its cash flow. However, this is balanced by less strong cash position numbers, including a current ratio under 1, which points to a need for effective cash handling to meet near-term needs.
On earnings, McKesson does very well in its effectiveness. Its Return on Invested Capital (ROIC) of 28.37% is with the best in its industry, showing a strong ability to create earnings from its capital. While its profit and operating margins are average for the industry, its gross margin is lower—a typical feature of the distribution business but an point for investors to see.
Conclusion
MCKESSON CORP shows an example of the affordable growth screening thinking. It has the necessary part of good, steady earnings growth. This growth is not valued at a very high level but is instead priced in a fair context compared to industry peers and future predictions. The company is backed by notable capital effectiveness and a very good debt position, though its cash position needs watching.
For investors systematically looking for companies that mix growth possibility with price consciousness, McKesson justifies further study based on this basic picture. It shows the kind of candidate a careful screening process is made to find.
You can review other stocks that meet similar "Affordable Growth" standards by using this set stock screener.
Disclaimer: This article is for information only and does not make financial advice, a suggestion, or an offer or request to buy or sell any securities. The study is based on data and ratings given by ChartMill.com as of the date of writing. Investors should do their own separate research and think about their personal financial situation before making any investment choices. Past results do not guarantee future outcomes.